Search

everythinglearnresearchcommunity

for

Search:↓

New drug shows promise for better hair growth in baldness treatment.

Oestrogens are key for bone growth during puberty in both boys and girls.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

New compounds may soon be tested to treat excessive hair growth in women.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Skin reactions from cancer treatments might predict how well the treatments work.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Ten miRNAs may play key roles in starting secondary hair follicle development in sheep foetuses.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.